GeekWire
FEBRUARY 15, 2022
Adaptive Biotechnologies , which develops technology to assess the immune response, posted $154.3 Net loss for 2021 came in at $207.3 million in the fourth quarter, up 26%, with a net loss of $61.4 Adaptive moved into its new headquarters in September. Co-founders Harlan (left) and Chad Robins on the new plaza. million in 2020.
GeekWire
AUGUST 23, 2021
In a region better known for its tech startups and legions of software engineers, it’s biotech companies that have helped lead a recent IPO boom in the state of Washington, accounting for eight of 11 firms joining the public markets via a traditional IPO over the past year. based biotech company went public. Absci Photo).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
GeekWire
SEPTEMBER 17, 2020
Formerly known as M3 Biotechnology, the company is led by Dr. Leen Kawas , a 35-year-old CEO who will be the first woman to guide a company to an initial public offering in Washington state in more than two decades. In its IPO paperwork, Athira reported a net loss of $5.2 billion in the largest software IPO ever.
GeekWire
DECEMBER 9, 2022
Banzai , a Seattle marketing software startup, announced Thursday that it will go public after it agreed to merge with a special-purpose acquisition company. Seattle businesses including Porch, Nautilus Biotechnology, Rover and Leafly have all gone public via SPAC within the last two years. Banzai CEO Joe Levy. Banzai Photo).
GeekWire
AUGUST 26, 2020
The company, previously known as M3 Biotechnology, is led by Dr. Leen Kawas , a 35-year-old entrepreneur originally from Jordan. In its IPO paperwork, Athira reports a net loss of $5.2 It would be the first Seattle biotech to go public since Adaptive Biotechnologies IPO’d last year. million in 2019, and a loss of $3.8
GeekWire
JUNE 24, 2020
million net loss and $132.5 million net loss and $94.8 Singh previously co-founded travel expense software giant Concur and brought on fellow Concur co-founder Mike Hilton as chief product officer at Accolade, which originally launched back in 2007. It plans to trade on the Nasdaq exchange under the ticker ACCD. Vancouver, Wash.-based
GeekWire
SEPTEMBER 18, 2020
It’s the latest privately-held company to test the public markets amid a rush of IPOs in recent months, particularly in biotech and software , despite the ongoing pandemic. ” Athira, previously known as M3 Biotechnology, plans to double the size of its 20-person team as it relocates into a larger facility in Bothell, Wash.
Expert insights. Personalized for you.
97 
Let's personalize your content